ATLANTA – Southeast BIO (SEBIO) announced the winners of the Fourth Annual SEBIO Awards in a ceremony held at its Twelfth Annual Investor Forum in Atlanta, Georgia. (more…)

Southeast BIO (SEBIO) announced the winners of the Fourth Annual SEBIO Awards in a ceremony held at its Twelfth Annual Investor Forum in Atlanta, Georgia on November 4th. The awards honored companies in the following categories: Southeast (SE) Deal of the Year: Initial Funding; SE Deal of the Year: Venture Capital Transaction, and SE Deal of the Year: Strategic Transaction. In addition, the organization awarded its SE Leadership Award to an individual or organization that made a notable contribution to the growth of the life sciences industry in the region over the last year. The winners were InVasc Therapeutics, Inc., TearScience, Inc., Alimera Sciences, Inc., and David Day of the University of Florida, respectively. (more…)

DURHAM, NC – Tranzyme Inc., a Durham-based drug developer, has filed for a $75 million initial public offering of stock. (more…)

Southeast BIO’s (SEBIO) Twelfth Annual Investor Forum exuded an air of optimism for emerging life sciences companies in the Southeast region as executives from established enterprises told their recent financing, partnering, and exit success stories to nearly 350 attendees. The Investor Forum took place on November 3-4th in Atlanta, Georgia. (more…)

COLUMBIA, SC - SC Launch has invested an undisclosed amount in Vitasol, a life science company focused on improving therapies in emergency medicine and critical care.SC Launch typically invests $250,000 or less in South Carolina start-ups. (more…)

BLACKSBURG, VA -Intrexonhas closed on a $37.5 million mixed securities offering,  according to a regulatory filing. The company’s D round attracted 65 investors. Intrexon is developing a cancer therapy that enhances the immune system. (more…)

ATLANTA – Atlanta-based Arbor Pharmaceuticals, a pharmaceutical firm specialized in the pediatric market has closed on a$34.8 million financing. (more…)

BIRMINGHAM, AL – Agenta Biotechnologies Inc., based in Birmingham, has received a $1.1 million grant from the National Institutes of Health and National Institute of Dental and Craniofacial Research for the further development of a biologically activated membrane to improve soft tissue healing associated with oral surgery. This grant is funded by the Small Business Innovative Research (SBIR) program of the NIH and is the second such award received by Agenta. (more…)

MORRISVILLE, NC – Medical device firm nContact Surgical has closed on $16 million in funding led by existing investor Harbert Venture Partners. New investor ZMV Associates also participated in the round. TechJournal South reported the company had raised $13.1 million of the round in October. (more…)

WASHINGTON, DC – Hundreds of life sciences companies throughout the Southeast will receive grants and credits from the Qualifying Therapeutic Discovery Project Program. (more…)